Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.

Two of the distinguished in the latest edition of the Fronteras del Conocimiento FBBVA, endocrinologist Daniel J. Drucker and ...

Obesity and heart failure often go together, making treatment more complicated. Now, health experts have released new ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

A new algorithm enables smartwatch fitness trackers to more accurately monitor energy expenditure of people with obesity ...

In addition, a new study by the World Obesity Federation attributes more than 1,500 premature deaths recorded in 2021 in the ...

But it’s taking neither seriously. Despite the fact that more than 64% of people in the UK are either overweight or obese our ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...

Obesity is independently associated with financial hardship and food insecurity, according to recent research.

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

Referrals to an obesity clinic almost doubled after a novel educational intervention addressed negative attitudes and ...